The study aims to measure CMV-specific CD8+ lymphocyte function post-allogeneic-HSCT by using the QuantiFERON®-CMV assay clinical trials

Evaluation of a laboratory test called QuantiFERON Cytomegalovirus in allogeneic stem cells transplant patients to assess its ability to detect the timing when the patients' immune system can control cytomegalovirus infection, thus allowing the clinical team the discontinuation of antiviral prophylaxis

This study looks at a blood test (QuantiFERON-CMV) for people who've had a stem cell transplant. It aims to see if the test can tell doctors when a patient's immune system is strong enough to fight a virus called CMV, potentially helping to decide when to stop antiviral medicine.